Wilkins Investment Counsel Inc. Has $9.76 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Wilkins Investment Counsel Inc. lessened its stake in Colgate-Palmolive (NYSE:CLFree Report) by 0.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 107,389 shares of the company’s stock after selling 450 shares during the quarter. Colgate-Palmolive accounts for about 1.4% of Wilkins Investment Counsel Inc.’s holdings, making the stock its 29th biggest position. Wilkins Investment Counsel Inc.’s holdings in Colgate-Palmolive were worth $9,763,000 as of its most recent filing with the SEC.

Several other large investors have also recently added to or reduced their stakes in CL. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth $26,000. Centricity Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth $27,000. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth $32,000. Briaud Financial Planning Inc acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth $32,000. Finally, Wintrust Investments LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth $33,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the stock. JPMorgan Chase & Co. increased their price target on shares of Colgate-Palmolive from $97.00 to $99.00 and gave the stock an “overweight” rating in a research note on Friday, March 14th. Piper Sandler dropped their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Raymond James reaffirmed an “outperform” rating and set a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Finally, Stifel Nicolaus decreased their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Hold” and an average target price of $101.72.

Read Our Latest Stock Analysis on Colgate-Palmolive

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $90.44 on Thursday. The firm has a fifty day moving average price of $89.19 and a two-hundred day moving average price of $94.41. The company has a market cap of $73.39 billion, a PE ratio of 25.69, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the business posted $0.87 earnings per share. Analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.